Annual general meeting

PreludeDx™ to Present DCISionRT® and Novel Residual Risk Subtype Study Results During Scientific Oral Session at ASBrS 2022 Annual Meeting

Retrieved on: 
Tuesday, March 29, 2022

"We remain committed to continuous innovation to enable physicians and patients to make personalized early-stage cancer treatment decisions and enhance patient outcomes."

Key Points: 
  • "We remain committed to continuous innovation to enable physicians and patients to make personalized early-stage cancer treatment decisions and enhance patient outcomes."
  • DCISionRT is the only risk assessment test for patients with ductal carcinoma in situ (DCIS) that predicts radiation therapy benefit.
  • DCISionRT's intelligent reporting provides a woman's recurrence risk after breast conserving surgery alone and with the addition of radiation therapy.
  • PreludeDx is a leading personalized breast cancer diagnostics company dedicated to serving breast cancer patients and physicians worldwide.

Notice of Annual General Meeting in TF Bank AB

Retrieved on: 
Monday, March 28, 2022

no 556158-1041, ("TF Bank" or the "Company") are hereby invited to attend the Annual General Meeting on May 3, 2022.

Key Points: 
  • no 556158-1041, ("TF Bank" or the "Company") are hereby invited to attend the Annual General Meeting on May 3, 2022.
  • The Nomination Committee proposes that the Board of Directors shall consist of six (6) members appointed by the Annual General Meeting.
  • Therefore, this is the main alternative (item 16 on the agenda for the Annual General Meeting).
  • The Board of Directors proposes that the Annual General Meeting resolves that a maximum of 26,000 of the Acquired shares in the bank may be sold/transferred as follows.

Nomination committee's proposal to TF Bank's Annual General Meeting 2022

Retrieved on: 
Monday, March 28, 2022

Re-election of John Brehmer, Michael Lindengren, Sara Mindus and Mari Thjmeas well as new election of Fredrik Oweson and Niklas Johansson is proposed, all until the next Annual General Meeting.

Key Points: 
  • Re-election of John Brehmer, Michael Lindengren, Sara Mindus and Mari Thjmeas well as new election of Fredrik Oweson and Niklas Johansson is proposed, all until the next Annual General Meeting.
  • Furthermore, the nomination committee proposes the re- election of John Brehmer as Chairman of the Board until the next Annual General Meeting.
  • It is the view of the Nomination Committee that the proposed board members have the experience and knowledge deemed necessary to secure the Company's and the owners' interests.
  • Tiberon AB, the second largest shareholder in TF Bank, declined representation in the Nomination Committee.

Decisions of the Annual General Meeting and Board of Directors of Caverion Corporation

Retrieved on: 
Monday, March 28, 2022

The Annual General Meeting elected a Chairman, a Vice Chairman and five (5) ordinary members to the Board of Directors.

Key Points: 
  • The Annual General Meeting elected a Chairman, a Vice Chairman and five (5) ordinary members to the Board of Directors.
  • The Annual General Meeting decided that the annual fees for the members of the Board of Directors remain unchanged and that the following annual fees will be paid:
    Chairman of the Board of Directors EUR 79,200,
    .Approximately 40% of the annual remuneration will be paid in Caverion Corporation's shares.
  • The Annual General Meeting authorised the Board of Directors to decide on the repurchase and/or on the acceptance as pledge of the Company's own shares in accordance with the proposal by the Board of Directors.
  • The Annual General Meeting authorised the Board of Directors to decide on share issues in accordance with the proposal by the Board of Directors.

Update on the Proxy Fight Launched at Aerojet Rocketdyne by Warren Lichtenstein, CEO of Steel Partners, and his Friends Martin Turchin, James Henderson and Audrey McNiff

Retrieved on: 
Monday, March 28, 2022

They have voiced disappointment that, at a critical time for Aerojet Rocketdyne, Mr. Lichtenstein has caused this disruption to the Company.

Key Points: 
  • They have voiced disappointment that, at a critical time for Aerojet Rocketdyne, Mr. Lichtenstein has caused this disruption to the Company.
  • Because shareholder interests must be protected, the Independent Directors are prepared to take the steps necessary to ensure that shareholder democracy prevails.
  • Now, it is time to turn to the substance of the issues facing the Company today as a result of Steel Partners and Mr. Lichtenstein's conduct.
  • The Incumbent Directors will furnish the definitive proxy statement to its stockholders, together with a WHITE proxy card.

Tablet Containing CBD Shows Promise in Reducing Post-Operative Pain

Retrieved on: 
Friday, March 25, 2022

CHICAGO, March 25, 2022 /PRNewswire/ -- An orally absorbed tablet containing cannabidiol (CBD) effectively reduces pain after shoulder surgery with no safety concerns, a new study finds.

Key Points: 
  • CHICAGO, March 25, 2022 /PRNewswire/ -- An orally absorbed tablet containing cannabidiol (CBD) effectively reduces pain after shoulder surgery with no safety concerns, a new study finds.
  • Additionally, CBD has the benefit of pain relief without the psychotropic effects associated with THC or marijuana."
  • On the first day after surgery, patients receiving CBD experienced on average 23 percent less pain as measured by the visual analog scale (VAS) pain score compared to patients receiving the placebo, highlighting that in patients with moderate pain, CBD may render a significant benefit.
  • Further analysis also showed that patients receiving 50 mg of CBD reported lower pain and higher satisfaction with pain control compared to patients receiving placebo.

Bed Bath & Beyond Inc. Announces Cooperation Agreement with Ryan Cohen

Retrieved on: 
Friday, March 25, 2022

UNION, N.J., March 25, 2022 /PRNewswire/ -- Bed Bath & Beyond Inc. (Nasdaq: BBBY) ("Bed Bath & Beyond" or the "Company") today announced that it has entered into a cooperation agreement with Ryan Cohen and RC Ventures LLC (together, "RC Ventures"), the beneficial owners of approximately 9.8% of the Company's outstanding shares. As part of the agreement, three of RC Ventures' director designees – Marjorie L. Bowen, Shelly C. Lombard, and Ben Rosenzweig – will immediately join Bed Bath & Beyond's Board of Directors (the "Board") as new Independent Directors, and they will also stand for election as part of the Company's slate at the 2022 Annual Meeting of Shareholders (the "Annual Meeting"). The Board will temporarily expand to 14 members before reverting to 11 members following the Annual Meeting. The three new directors collectively bring deep expertise in capital allocation, corporate governance, strategic planning, and transactions.

Key Points: 
  • UNION, N.J., March 25, 2022 /PRNewswire/ -- Bed Bath & Beyond Inc. (Nasdaq: BBBY) ("Bed Bath & Beyond" or the "Company") today announced that it has entered into a cooperation agreement with Ryan Cohen and RC Ventures LLC (together, "RC Ventures"), the beneficial owners of approximately 9.8% of the Company's outstanding shares.
  • In conjunction with the cooperation agreement, Bed Bath & Beyond today announced that Ms. Bowen and Mr. Rosenzweig, will join a four-member Strategy Committee focused on exploring alternatives to unlock greater value from the Company's buybuy BABY banner.
  • The Board is highly committed to fundamentally reshaping Bed Bath & Beyond for our customers while driving growth and profitability across its banners.
  • Additionally, the Company is a partner in a joint venture which operates retail stores in Mexico under the name Bed Bath & Beyond.

Inhibrx Announces Details of Presentations at 2022 AACR Annual Meeting

Retrieved on: 
Thursday, March 24, 2022

"We believe that both of these platforms are foundational to our continued efforts aimed at growing our emerging pipeline of therapeutic candidates in oncology."

Key Points: 
  • "We believe that both of these platforms are foundational to our continued efforts aimed at growing our emerging pipeline of therapeutic candidates in oncology."
  • Details on poster presentations are shared below:
    Posters will be available on-demand on the AACR website for attendees ( www.aacr.org ) beginning at 12:00 PM CDT on April 8, 2022 until July 13, 2022.
  • Upon release at AACR, the scientific posters will be accessible through Inhibrx's website at https://inhibrx.investorroom.com/events-and-presentations .
  • Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases.

New Study Finds Surface Imaging Provides Highly Accurate Models of The Body for Scoliosis Surgeons

Retrieved on: 
Thursday, March 24, 2022

CHICAGO, March 24, 2022 /PRNewswire/ -- A new study that includes researchers at Hospital for Special Surgery (HSS) in New York City has found that a technique called 3dMD, which uses an array of highly sensitive cameras and can image the entire body in a fraction of a second, generates extremely accurate and reliable models of the torso that can guide the management of adolescents with scoliosis.

Key Points: 
  • "When you see someone with a spinal deformity, you're not necessarily visualizing the shape of the spine underneath," he said.
  • "Three-dimensional (3-D) surface scanning is analogous to what you see visually, whereas x-rays or MRI are often much different from what you see on the surface.
  • "It gives us very accurate information to begin with, and it's important to start with sound data," Dr. Hillstrom noted.
  • What was previously unknown was how well these images of the body's surface conform to the anatomy beneath the skin.

Cincinnati Financial Corporation Announces Internet Availability of Proxy Materials and Webcast for 2022 Annual Meeting of Shareholders

Retrieved on: 
Thursday, March 24, 2022

CINCINNATI, March 24, 2022 /PRNewswire/ -- Cincinnati Financial Corporation (NASDAQ:CINF) today announced the internet availability of materials for its 2022 Annual Meeting of Shareholders the 2021 Annual Report on Form 10-K, the 2022Annual Shareholder Meeting Notice and Proxy Statement and the 2022 Annual Letter to Shareholders.

Key Points: 
  • CINCINNATI, March 24, 2022 /PRNewswire/ -- Cincinnati Financial Corporation (NASDAQ:CINF) today announced the internet availability of materials for its 2022 Annual Meeting of Shareholders the 2021 Annual Report on Form 10-K, the 2022Annual Shareholder Meeting Notice and Proxy Statement and the 2022 Annual Letter to Shareholders.
  • The 2022 Annual Meeting of Shareholders will be held on Saturday, May 7, at9:30a.m.
  • The company invites those unable to attend the meeting in person to visit cinfin.com/investors for a live, listen-only webcast of the meeting.
  • Subject to shareholder preferences, most shareholders will receive those instructions via a mailed Notice of Internet Availability of Proxy Materials that encourages online reading of proxy materials.